Evommune
IPONovel Therapies for Chronic Inflammatory Disease
Public · Redwood City, United States · Founded 2020 · $255.5M raised
- Headquarters
- Redwood City, California
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- evommune.com
- Total Funding
- $255.5M
- Last Round
- $115.0M Series COct 2024
- Rounds
- 4
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Clinical-stage biopharma developing novel therapies for immune-mediated chronic inflammatory diseases including atopic dermatitis.
Summary
Evommune is a Biotech company based in Redwood City, United States, founded in 2020. It has raised $255.5M in total across 4 rounds, most recently a $115.0M Series C round in Oct 2024. Investors include RA Capital Management, Arix Bioscience and Sectoral Asset Management.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2025
Sign up to see all 5 events
Funding: Series A through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/evommune"><img src="https://indexed.vc/api/badge/company/evommune" alt="Evommune on Indexed.vc" width="260" height="76" /></a>